Iron and aluminum homeostasis in neural disorders.
- 1 September 1994
- journal article
- review article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 102 (suppl 3) , 207-213
- https://doi.org/10.1289/ehp.94102s3207
Abstract
The brain is the most compartmentalized organ. It is also highly aerobic. Because nerve cells grow but do not regenerate, the brain is the organ best suited for the accumulation of metabolic errors colocalized in specific areas of the brain over an extended period. Alzheimer's disease (AD) is primarily a neurological disorder of the elderly. It is suggested that this disorder results from the accumulation of such errors, and that AD onset aluminum and iron contribute to but do not necessarily initiate the onset of the disease. In vitro and in vivo evidence summarized here suggests that this is effected by interfering in the utilization of glucose and glucose-6-phosphate, and sequestration of iron by ferritin. beta-amyloid precusor proteins (beta-APPs) are normal components of the human brain and some other tissues. Proteolysis of these, presumably by serine proteases, generates a 39 to 42 amino acid long peptide, the alpha-amyloid (beta-AP). In AD brains, beta-AP aggregates into plaque, the hallmark of AD brains. Some of the alpha-APPs also contain a 56 amino acid long segment which inhibits serine proteases. We show that in vitro, at pH 6.5, aluminum activates beta-chymotrypsin 2-fold and makes it dramatically resistant to protease inhibitors such as bovine pancreatic trypsin inhibitor (bPTI) or its mimic present in the beta-amyloid precursor proteins (beta-APPs). Iron and oxygen are reported to favor cross-linking of beta-AP in vitro.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 43 references indexed in Scilit:
- Ferritin: The role of aluminum in ferritin functionNeurobiology of Aging, 1991
- Deciphering Alzheimer's Disease: The Amyloid Precursor Protein Yields New CluesScience, 1990
- Immunisation practice in developed countriesThe Lancet, 1990
- Altered glucose metabolism in microvessels from patients with Alzheimer's diseaseAnnals of Neurology, 1989
- Effect of long-term feeding of aluminium chloride on hexokinase and glucose-6-phosphate dehydrogenase in the brainToxicology, 1988
- Effect of 5-minute ischemia on regional pH and energy state of the gerbil brain: relation to selective vulnerability of the hippocampus.Stroke, 1987
- ALUMINOSILICATES AND SENILE PLAQUE FORMATION IN ALZHEIMER'S DISEASEThe Lancet, 1986
- Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron saltsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985
- The competitive equilibrium between aluminium and ferric ions for the binding sites of transferrinFEBS Letters, 1984
- Plasma aluminum is bound to transferrinLife Sciences, 1983